Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Tatari Calderone, Zohreh ^a   Stojakovic, Milica ^a,b   Dewan, Ramita ^a   Bouder, Gama Le ^a   Jankovic, Dragana ^c   Vukmanovic, Stanislav ^a,b  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; BIOLOGICAL MARKER;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MYELITIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; THYMECTOMY; THYMUS; AGING; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

AGING; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD5; BIOLOGICAL MARKERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; PHENOTYPE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84856807140     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-8     Document Type: Article

References (74)

1. Sadighi Akha AA, Miller RA. Signal transduction in the aging immune system. Curr Opin Immunol 2005, 17:486-491. 10.1016/j.coi.2005.07.004, 16061371.
2. Miller RA. The aging immune system: primer and prospectus. Science 1996, 273:70-74. 10.1126/science.273.5271.70, 8658199.
3. Lerner A, Yamada T, Miller RA. Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur J Immunol 1989, 19:977-982. 10.1002/eji.1830190604, 2666144.
4. Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997, 160:79-90. 10.1111/j.1600-065X.1997.tb01029.x, 9476667.
5. Hirokawa K. Age-related changes of signal transduction in T cells. Exp Gerontol 1999, 34:7-18. 10.1016/S0531-5565(98)00067-9, 10197724.
6. Grossmann A, Maggio-Price L, Jinneman JC, Rabinovitch PS. Influence of aging on intracellular free calcium and proliferation of mouse T-cell subsets from various lymphoid organs. Cell Immunol 1991, 135:118-131. 10.1016/0008-8749(91)90259-E, 1826862.
7. Thoman ML, Weigle WO. Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol 1981, 127:2102-2106.
8. Linton PJ, Haynes L, Klinman NR, Swain SL. Antigen-independent changes in naive CD4 T cells with aging. J Exp Med 1996, 184:1891-1900. 10.1084/jem.184.5.1891, 2192899, 8920876.
9. Scollay RG, Butcher EC, Weissman IL. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 1980, 10:210-218. 10.1002/eji.1830100310, 7379836.
10. Metcalf D, Moulds R, Pike B. Influence of the spleen and thymus on immune responses in ageing mice. Clin Exp Immunol 1967, 2:109-120. 1578823, 4291612.
11. Hartwig M, Steinmann G. On a causal mechanism of chronic thymic involution in man. Mech Ageing Dev 1994, 75:151-156. 10.1016/0047-6374(94)90083-3, 7823637.
12. Kadish JL, Basch RS. Hematopoietic thymocyte precursors. I. Assay and kinetics of the appearance of progeny. J Exp Med 1976, 143:1082-1099. 10.1084/jem.143.5.1082, 2190196, 4575.
13. Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu Rev Immunol 2000, 18:83-111. 10.1146/annurev.immunol.18.1.83, 10837053.
14. Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997, 157:61-72. 10.1111/j.1600-065X.1997.tb00974.x, 9255622.
15. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5:133-139.
16. Ge Q, Rao VP, Cho BK, Eisen HN, Chen J. Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/MHC epitopes and strength of their interaction with T cell receptors. Proc Natl Acad Sci USA 2001, 98:1728-1733. 10.1073/pnas.98.4.1728, 29325, 11172019.
17. Moses CT, Thorstenson KM, Jameson SC, Khoruts A. Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc Natl Acad Sci USA 2003, 100:1185-1190. 10.1073/pnas.0334572100, 298748, 12525694.
18. Kieper WC, Burghardt JT, Surh CD. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol 2004, 172:40-44.
19. Azzam HS, DeJarnette JB, Huang K, Emmons R, Park CS, Sommers CL, El-Khoury D, Shores EW, Love PE. Fine tuning of TCR signaling by CD5. J Immunol 2001, 166:5464-5472.
20. Smith K, Seddon B, Purbhoo MA, Zamoyska R, Fisher AG, Merkenschlager M. Sensory adaptation in naive peripheral CD4 T cells. J Exp Med 2001, 194:1253-1261. 10.1084/jem.194.9.1253, 2195983, 11696591.
21. Kassiotis G, Zamoyska R, Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med 2003, 197:1007-1016. 10.1084/jem.20021812, 2193871, 12707300.
22. Perez-Villar JJ, Whitney GS, Bowen MA, Hewgill DH, Aruffo AA, Kanner SB. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol 1999, 19:2903-2912. 84084, 10082557.
23. Stojakovic M, Salazar-Fontana LI, Tatari-Calderone Z, Badovinac VP, Santori FR, Kovalovsky D, Sant'Angelo D, Harty JT, Vukmanovic S. Adaptable TCR avidity thresholds for negative selection. J Immunol 2008, 181:6770-6778.
24. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006, 6:883-894. 10.1038/nri1977, 17110956.
25. Zeh HJI, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC. High avidity CTLs for two self antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 1999, 162:989-994.
26. Derby MA, Alexander-Miller MA, Tse R, Berzofsky JA. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol 2001, 166:1690-1697.
27. Holler PD, Chlewiski LK, Kranz DM. TCRs with high affinity for foreign pMHC show self reactivity. Nature Immunol 2003, 4:55-62.
28. Santori FR, Brown SM, Vukmanovic S. Genomics-based identification of self-ligands with T cell receptor-specific biological activity. Immunol Rev 2002, 190:146-160. 10.1034/j.1600-065X.2002.19011.x, 12493012.
29. Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 2000, 406:739-742. 10.1038/35021081, 10963600.
30. Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES. Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Nat Acad Sci USA 2001, 98:6818-6823. 10.1073/pnas.111161198, 34436, 11391002.
31. Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B, et al. TCR affinity and negative regulation limit autoimmunity. Nat Med 2004, 10:1234-1239. 10.1038/nm1114, 15467726.
32. Han B, Serra P, Yamanouchi J, Amrani A, Elliott J, Dickie P, Dilorenzo T, Santamaria P. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 2005, 115:1879-1887. 10.1172/JCI24219, 1142112, 15937548.
33. Li L, Boussiotis VA. Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. J Mol Med 2006, 84:887-899. 10.1007/s00109-006-0098-5, 16972086.
34. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II restricted T cells anergized in vivo. J Exp Med 1988, 187:177-183.
35. Sundstedt A, Hoiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol 1997, 158:180-186.
36. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 1999, 11:1625-1634. 10.1093/intimm/11.10.1625, 10508180.
37. Seewaldt S, Alferink J, Forster I. Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur J Immunol 2002, 32:3607-3616. 10.1002/1521-4141(200212)32:12<3607::AID-IMMU3607>3.0.CO;2-O, 12516547.
38. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003, 21:139-176. 10.1146/annurev.immunol.21.120601.141107, 12414722.
39. Palmer E. The T-cell antigen receptor: a logical response to an unknown ligand. J Recept Signal Transduct Res 2006, 26:367-378. 10.1080/10799890600919094, 17118787.
40. Vukmanovic S, Neubert TA, Santori FR. Could TCR antagonism explain associations between MHC genes and disease?. Trends Mol Med 2003, 9:139-146. 10.1016/S1471-4914(03)00029-7, 12727139.
41. Jameson SC. T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol 2005, 17:231-237. 10.1016/j.smim.2005.02.003, 15826828.
42. Jabbari A, Harty JT. Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation. J Immunol 2005, 175:4829-4833.
43. Oehen S, Brduscha-Riem K. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies?. EurJImmunol 1999, 29:608-614.
44. Kieper WC, Jameson SC. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA 1999, 96:13306-13311. 10.1073/pnas.96.23.13306, 23943, 10557316.
45. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. JExpMed 2000, 192:557-564.
46. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. JExpMed 2000, 192:549-556.
47. Murali-Krishna K, Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J Immunol 2000, 165:1733-1737.
48. Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005, 26:5-8. 10.1016/j.it.2004.11.006, 15629402.
49. Hochberg MC. The epidemiology of systemic lupus erythematosus. Dubois' Lupus Erythematosus 1997, 49. Baltimore: Williams & Wilkins, Wallace DJ, Hahn BH.
50. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989, 112:1419-1428. 10.1093/brain/112.6.1419, 2597989.
51. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Inf Dis 2000, 31:578-585.
52. Stojakovic M, Tatari-Calderone Z, Maric C, Hoang A, Vukmanovic S. Paradoxical arrest in lupus activity in BXSB mice with highly autoreactive T cells. Lupus 2010, 19:182-191. 10.1177/0961203309350756, 19946033.
53. Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 2011, 32:232-239. 10.1016/j.it.2011.02.007, 21493143.
54. Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006, 116:3252-3257. 10.1172/JCI29251, 1635165, 17099776.
55. Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B, et al. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol 2008, 38:576-586. 10.1002/eji.200737271, 18200504.
56. Hobb S, Weigle WO, Ernst DN. Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell Immunol 1994, 154:264-272. 10.1006/cimm.1994.1076, 7510582.
57. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274. 10.1016/0092-8674(93)80068-P, 8402911.
58. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003, 20:281-285. 10.1016/S0896-8411(03)00044-1, 12791313.
59. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994, 24:1434-1440. 10.1002/eji.1830240629, 7515815.
60. Nagelkerken L, Blauw B, Tielemans M. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int Immunol 1997, 9:1243-1251. 10.1093/intimm/9.9.1243, 9310827.
61. Cannella B, Gao YL, Brosnan C, Raine CS. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 1996, 45:735-746. 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V, 8892085.
62. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998, 161:3299-3306.
63. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998, 187:537-546. 10.1084/jem.187.4.537, 2212155, 9463404.
64. Samoilova EB, Horton JL, Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell Immunol 1998, 188:118-124. 10.1006/cimm.1998.1365, 9756642.
65. Beebe AM, Cua DJ, de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002, 13:403-412. 10.1016/S1359-6101(02)00025-4, 12220553.
66. Llorente L, Richaud-Patin Y, García-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcón-Segovia D, Wijdenes J, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000, 43:1790-1800. 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2, 10943869.
67. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994, 179:305-310. 10.1084/jem.179.1.305, 2191319, 8270873.
68. Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J. IL-10 regulates murine lupus. J Immunol 2002, 169:2148-2155.
69. Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, Croker BP, Morel L. IL-10 regulation of lupus in the NZM2410 murine model. Lab Investig 2006, 86:1136-1148.
70. Ely KH, Roberts AD, Kohlmeier JE, Blackman MA, Woodland DL. Aging and CD8+ T cell immunity to respiratory virus infections. Exp Gerontol 2007, 42:427-431. 10.1016/j.exger.2006.11.017, 1964788, 17197143.
71. Janicki CN, Jenkinson SR, Williams NA, Morgan DJ. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. Cancer Res 2008, 68:2993-3000. 10.1158/0008-5472.CAN-07-5008, 18413769.
72. Santori FR, Popmihajlov Z, Badovinac VP, Smith C, Radoja S, Harty JT, Vukmanovic S. TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex. J Immunol 2007, 178:6109-6114.
73. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 1999, 163:2937-2943.
74. Oliver AR, Lyon GM, Ruddle NH. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol 2003, 171:462-468.